Please login to the form below

Not currently logged in
Email:
Password:

genetic testing

This page shows the latest genetic testing news and features for those working in and with pharma, biotech and healthcare.

Alexion adds to pipeline with $1.2bn Syntimmune buy

Alexion adds to pipeline with $1.2bn Syntimmune buy

A lot of its efforts have been directed at bringing forward ravulizumab (ALXN1210), a Soliris follow-up with improved dosing frequency which has cleared phase 3 testing and is already submitted ... $855m, adding orally-active copper binder WTX-101 in

Latest news

  • Genetic testing: nothing to write home about? Genetic testing: nothing to write home about?

    2. The point of this month’s column is not to debate the merits of at-home genetic testing. ... But we must not conflate apples and oranges by using comparisons to today’s at-home genetic testing with the home pregnancy tests of yesteryear.

  • FDA approves another home genetic testing service FDA approves another home genetic testing service

    The US Food and Drug Administration (FDA) has authorised another one of 23andMe’s home genetic kits, and this one tests if certain women are at an increased risk of developing ... Known as a genetic health risk (GHR) report, the kit analyses DNA

  • Lundbeck partners with 23andMe on first-of-its-kind study Lundbeck partners with 23andMe on first-of-its-kind study

    To this end, we expect the study to provide detailed insights into the interaction of mood symptoms, cognitive processes and environmental factors, and to link these factors to genetic data. ... changed its mind on 23andMe’s genetic testing kits.

  • FDA changes its mind on 23andMe's genetic testing kits FDA changes its mind on 23andMe's genetic testing kits

    The FDA has officially approved a home genetic test kit developed by 23andMe, four years after ordering the company to stop providing the service. ... what is expected to open the door for more direct-to-consumer (DTC) genetic test approvals.

  • EC approves Bial’s Parkinson’s disease therapy EC approves Bial’s Parkinson’s disease therapy

    Last year the Google-backed genetic testing company 23andMe signed a $60m research deal with Roche subsidiary Genentech to generate whole genome sequencing data for about 3, 000 people with

More from news
Approximately 4 fully matching, plus 26 partially matching documents found.

Latest Intelligence

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    In the US and Canada, the company has launched Alynlam Act, a free of charge genetic testing and counselling service. ... and for more of these genetic tests to be done.

  • Harnessing the power of genetics Harnessing the power of genetics

    Collaboration and data management offer huge potential for improving testing and analysis and the subsequent provision of advice to patients. ... Routine genetic testing and analytics should be made available to all who need it, harnessing the power of

  • VIDEO interview: Neil Weir, UCB VIDEO interview: Neil Weir, UCB

    According to Dr Weir, if a patient is taught about the basis of his disease, he is more willing to collaborate on the research side, providing blood or genetic testing at ... According to Dr Weir, by understanding the genetic make-up of patients with the

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • MDxHealth creates new global commercial team MDxHealth creates new global commercial team

    Swansiger becomes senior vice president of business development at the biotechnology company and brings over 15 years of experience in oncology and autoimmune genomic and genetic testing. ... Rentrop joins from Noviogendix, where he was responsible for

  • Sophia Genetics names Marylin Mermod Schule as CFO Sophia Genetics names Marylin Mermod Schule as CFO

    Commenting on her appointment, Marylin Mermod Schule said: “Sophia Genetics stands out among its peers in Europe in the rapidly growing field of genetic data analysis. . ... The growth of precision medicine and increasing public interest in the value

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • The dark side of direct-to-consumer genetic tests

    Blue Latitude Health speaks to two experts in the field of genetic testing to learn about this issue and better understand how the industry can unite to solve these challenges. ... Some of the leading direct-to-consumer genetic testing companies use third

  • Genetic counsellors: the new healthcare influencers?

    In April 2018, Medicare &Medicaid Services  announced  patients with advanced cancer will have free access to genetic testing. ... to recommend genetic testing to high-risk breast cancer patients, despite the women asking for tests.

  • Personas: a top tool for personalising pharma marketing campaigns

    From health apps, such as the UK National Health Service and Babylon’s GP at Hand, to the novel ease of genetic testing, patients now have a greater ability to monitor

  • Big data, privacy and the rise of genomic testing

    Now,  organisations such as 23andMe are offering genetic testing and analysis to the public for less than £150, while BGI offers scientific grade Whole Genome Sequencing for as little as $600 ... There are  more than 5, 000  rare genetic diseases,

  • Lynch syndrome: a patient perspective

    Diagnosis of Lynch syndrome is achieved through genetic testing on a tissue sample (biopsy) or on blood targeting the aforementioned genes. ... If a genetic test is positive, the patient will have to increase the frequency of regular bowel screening.

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics